Soham Shukla

Employment

• GlaxoSmithKline USA Senior Manager
  2021 - Present
• GlaxoSmithKline USA Fellow
  2019 - 2021

Education

• Rutgers, The State University of New Jersey Masters of Science
  2019 - 2021
• Rutgers University Ernest Mario School of Pharmacy PharmD
  2013 - 2019

Projects & Funding

Projects & funding information is unavailable.

Publications (5)

• Cost-Effectiveness of Single-Inhaler Triple Therapy (FF/UMEC/VI) versus Tiotropium Monotherapy in Patients with Symptomatic Moderate-to-Very Severe COPD in the UK
  International Journal of Chronic Obstructive Pulmonary Disease 2023 DOI: 10.2147/COPD.S400707
  +Save
• Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial
  International Journal of Chronic Obstructive Pulmonary Disease 2022 DOI: 10.2147/COPD.S370577
  +Save
• Clinical and Economic Impact of Long-Term Inhaled Corticosteroid Withdrawal in Patients with Chronic Obstructive Pulmonary Disease Treated with Triple Therapy in Spain
  International Journal of Chronic Obstructive Pulmonary Disease 2022 DOI: 10.2147/COPD.S367708
  +Save
• Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model
  International Journal of Chronic Obstructive Pulmonary Disease 2021 DOI: 10.2147/COPD.S331636
  +Save
• Impact of body mass index on survival and serious adverse events in advanced non-small cell lung cancer treated with bevacizumab: a meta-analysis of randomized clinical trials
  Current Medical Research and Opinion 2021 DOI: 10.1080/03007995.2021.1900091
  +Save